Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
Merete Lund Hetland ; Ib Jarle Christensen ; Ulrik Tarp ; Lene Dreyer ; Annette Hansen ; Ib Tønder Hansen ; Gina Kollerup ; Louise Linde ; Hanne M Lindegaard ; Uta Engling Poulsen ; Annette Schlemmer ; Dorte Vendelbo Jensen ; Signe Jensen ; Gisela Hostenkamp ; Mikkel Østergaard ; All Departments of Rheumatology in Denmark
- Link:
- 10.1002/art.27227
- Emneord:
- Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Denmark; Female; Health Status; Humans; Immunoglobulin G; Male; Medication Adherence; Middle Aged; Prognosis; Receptors, Tumor Necrosis Factor; Registries; Remission Induction; Treatment Outcome; Young Adult
- Tidsskriftstitel:
- Arthritis and Rheumatism
- Udgivelsesår:
- 2010
- Vol./Bind:
- 62
- Nr.:
- 1
- Side:
- 22-32
- ISSN (Print):
- 0004-3591
- Sprog:
- Engelsk